(Q44036538)

English

Feasibility and cost-effectiveness of standardised second-line drug treatment for chronic tuberculosis patients: a national cohort study in Peru

scientific article

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

29 November 2017

Feasibility and cost-effectiveness of standardised second-line drug treatment for chronic tuberculosis patients: a national cohort study in Peru (English)

1 reference

Europe PubMed Central

PubMed publication ID

29 November 2017

0 references

0 references

cost-effectiveness analysis

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

Christopher Dye

10

object named as

Christopher Dye

1 reference

Europe PubMed Central

PubMed publication ID

29 November 2017

object named as

Cesar Bonilla

7

0 references

Mario Raviglione

object named as

Mario Raviglione

11

0 references

Elisabetta Rapiti

5

object named as

Elisabetta Rapiti

1 reference

Europe PubMed Central

PubMed publication ID

29 November 2017

author name string

Pedro G Suárez

1

1 reference

Europe PubMed Central

PubMed publication ID

29 November 2017

Katherine Floyd

2

1 reference

Europe PubMed Central

PubMed publication ID

29 November 2017

Jaime Portocarrero

3

1 reference

Europe PubMed Central

PubMed publication ID

29 November 2017

Edith Alarcón

4

1 reference

Europe PubMed Central

PubMed publication ID

29 November 2017

Gilbert Ramos

6

1 reference

Europe PubMed Central

PubMed publication ID

29 November 2017

Ivan Sabogal

8

1 reference

Europe PubMed Central

PubMed publication ID

29 November 2017

Isabel Aranda

9

1 reference

Europe PubMed Central

PubMed publication ID

29 November 2017

Marcos A Espinal

12

1 reference

Europe PubMed Central

PubMed publication ID

29 November 2017

language of work or name

0 references

publication date

1 June 2002

1 reference

Europe PubMed Central

PubMed publication ID

29 November 2017

1 reference

Europe PubMed Central

PubMed publication ID

29 November 2017

359

1 reference

Europe PubMed Central

PubMed publication ID

29 November 2017

9322

1 reference

Europe PubMed Central

PubMed publication ID

29 November 2017

1980-1989

1 reference

Europe PubMed Central

PubMed publication ID

29 November 2017

Global surveillance for antituberculosis-drug resistance, 1994-1997. World Health Organization-International Union against Tuberculosis and Lung Disease Working Group on Anti-Tuberculosis Drug Resistance Surveillance.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2908830-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Global trends in resistance to antituberculosis drugs. World Health Organization-International Union against Tuberculosis and Lung Disease Working Group on Anti-Tuberculosis Drug Resistance Surveillance.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2908830-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Standard short-course chemotherapy for drug-resistant tuberculosis: treatment outcomes in 6 countries

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2908830-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Treatment of 171 patients with pulmonary tuberculosis resistant to isoniazid and rifampin

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2908830-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Multidrug-Resistant Tuberculosis in Patients without HIV Infection

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2908830-X

7 January 2021

based on heuristic

inferred from DOI database lookup

The role of cost-effectiveness analysis in health and medicine. Panel on Cost-Effectiveness in Health and Medicine

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2908830-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Resource implications of patients with multidrug resistant tuberculosis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2908830-X

7 January 2021

based on heuristic

inferred from DOI database lookup

PUBLIC HEALTH: Responding to Market Failures in Tuberculosis Control

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2908830-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Multidrug-resistant tuberculosis: long term follow-up of 40 non-HIV-infected patients

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2908830-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Epidemiology, control and treatment of multidrug-resistant tuberculosis.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2908830-X

7 January 2021

based on heuristic

inferred from DOI database lookup

The treatment of multidrug-resistant tuberculosis in Turkey

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2908830-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Cost-effectiveness of chemotherapy for sputum smear-positive pulmonary tuberculosis in Malawi, Mozambique and Tanzania

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2908830-X

7 January 2021

based on heuristic

inferred from DOI database lookup

The long-term dynamics of tuberculosis and other diseases with long serial intervals: implications of and for changing reproduction numbers

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2908830-X

7 January 2021

based on heuristic

inferred from DOI database lookup

A cost-benefit analysis of BCG revaccination in the Czech Republic

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2908830-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Treatment of multidrug-resistant tuberculosis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2908830-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S0140-6736(02)08830-X

1 reference

Europe PubMed Central

PubMed publication ID

29 November 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

29 November 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q44036538&oldid=2117171072"